FDA recommends J&J vaccine (AD26) for emergency use authorization

Source: CNBC

The decision is non-binding but timely for ramping up of vaccinations. The single-shot, J and J vaccine (clinical name AD26) has been recommended for emergency use. This third COVID-19 vaccine should be available next week in the USA. Operation-wise, J&J vaccine is easier than the others already used to vaccinate people (Pfizer and Moderna). The vaccine has demonstrated effectiveness which appears to differ from site to site: 72% effectiveness in the USA; 66% in Latin America and 57% in South Africa. 

The great news about this vaccine is, it is single-dose. Just imagine what it takes for two doses given a month apart, imagine the savings of all sorts. Also, it can be stored betwen 36 to 46 deg F and again appreciate the savings.

The initial doses of this vaccine going out to the states and other organizations is estimated between 3 and 4 million. J and J is expected to provide some 20 million doses by the end of March.

The J and J vaccine may be better against the B.1.351 strain from South Africa. The two other vacciness are less effective against this strain.

How does J&J vaccine work:

This is a quote from the source below the quote:

"The J&J vaccine is what is known as a non-replicating viral vector vaccine, using a common cold virus called adenovirus 26.

Scientists made this vaccine by taking a small amount of genetic material that codes for a piece of the novel coronavirus and integrating it with a weakened version of adenovirus 26. J&J scientists altered this adenovirus so it can enter cells, but it cannot replicate and make people sick."

[https://www.msn.com/en-us/health/medical/how-the-johnson-johnson-covid-19-vaccine-works-and-why-it-s-important/ar-BB1ddvPZ]

More here on the FDA recommendation:

https://www.msn.com/en-us/health/medical/fda-panel-unanimously-recommends-third-covid-vaccine-as-j-26j-wins-key-vote-in-path-to-emergency-use/ar-BB1e3GJ5?ocid=uxbndlbing



https://www.msn.com/en-us/health/medical/fda-panel-unanimously-recommends-third-covid-vaccine-as-j-26j-wins-key-vote-in-path-to-emergency-use/ar-BB1e3GJ5?ocid=uxbndlbing

Operation Warp Speed: Light at the end of tunnel at last

Operation warp Speed has yielded results that will finally control this pandemic. Pfizer and Moderna, two of the 5 companies in the operation have yielded unbelievably excellent results. President Trump foresaw that the vaccines will be available by the end of the year, and they promptly did. Nay Sayers did voice their disbelief that it can be done in such a short time. 

He did appoint the most suitable candidate for heading the operation. Dr. Saloui Moncef was announced by President Trump in May 2020 to manage the development of vaccine. He could not have chosen anyone better. Well, President Trump did respect science in choosing him whatever may be his personal view of the virus/infection.

At last, there is hope for the end of this pandemic, thanks to the foresight of Operation Warp Speed team.

Here are some screen shots from a CNBC interview aired today.

Trick of the vaccine is in the pricing

No vaccine has proved to be the most effective so far, but the battle has begun.

Vaccine, at what price?

Her is something I saw on Bloomberg tv recently:

Indian Serum Institute, the world's largest bulk producer of the vaccine (Oxford Vaccine) will be producing it and distributing it at a very reasonable price. Thank Bill Gates and Melinda Foundation!

It is about $3/dose. Moderna appears too expensive for developing countries. 

Covid-19 Vaccine Hopefuls

Here is a list of vaccine hopefuls to combat the new coronavirus Covid-19.

https://www.benzinga.com/analyst-ratings/analyst-color/20/05/16056298/these-6-coronavirus-vaccine-candidates-are-the-likeliest-to-succeed-says-morgan-sta

According to BGR, a leading online destination for news and commentary focused on the mobile and consumer electronics markets, these are the companies/institutions that are further in bringing in a vaccine for the coronavirus.

According to Fauci, the new coronavirus is not addressed by a vaccine that can provide lifetime immunity and, at best it can provide immunity up to 12 months. It appears to change with time just like the cold virus. He notes with optimism that 100s of millions of doses may be available by 2021.

https://bgr.com/2020/06/03/fauci-vaccine-comments-coronavirus-immunity-length/